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Abstract
Background: There is little robust evidence relating to changes in health related quality of life (HRQL) in morbidly
obese patients following a multidisciplinary non-surgical weight loss program or laparoscopic Roux-en-Y Gastric
Bypass (RYGB). The aim of the present study was to describe and compare changes in five dimensions of HRQL in
morbidly obese subjects. In addition, we wanted to assess the clinical relevance of the changes in HRQL between
and within these two groups after one year. We hypothesized that RYGB would be associated with larger
improvements in HRQL than a part residential intensive lifestyle-intervention program (ILI) with morbidly obese
subjects.
Methods: A total of 139 morbidly obese patients chose treatment with RYGB (n=76) or ILI (n=63). The ILI
comprised four stays (seven weeks) at a specialized rehabilitation center over one year. The daily schedule was
divided between physical activity, psychosocially-oriented interventions, and motivational approaches. No special
diet or weight-loss drugs were prescribed. The participants completed three HRQL-questionnaires before treatment
and 1 year thereafter. Both linear regression and ANCOVA were used to analyze differences between weight loss
and treatment for five dimensions of HRQL (physical, mental, emotional, symptoms and symptom distress)
controlling for baseline HRQL, age, age of onset of obesity, BMI, and physical activity. Clinical relevance was
assessed by effect size (ES) where ES<.49 was considered small, between .50-.79 as moderate, and ES>.80 as large.
Results: The adjusted between group mean difference (95% CI) was 8.6 (4.6,12.6) points (ES=.83) for the physical
dimension, 5.4 (1.5–9.3) points (ES=.50) for the mental dimension, 25.2 (15.0–35.4) points (ES=1.06) for the emotional
dimension, 8.7 (1.8–15.4) points (ES=.37) for the measured symptom distress, and 2.5 for (.6,4.5) fewer symptoms
(ES=.56), all in favor of RYGB. Within-group changes in HRQOL in the RYGB group were large for all dimensions of
HRQL. Within the ILI group, changes in the emotional dimension, symptom reduction and symptom distress were
moderate. Linear regression analyses of weight loss on HRQL change showed a standardized beta-coefficient of
–.430 (p<.001) on the physical dimension, –.288 (p=.004) on the mental dimension, –.432 (p<.001) on the emotional
dimension, .287 (p=.008) on number of symptoms, and .274 (p=.009) on reduction of symptom pressure.
Conclusions: Morbidly obese participants undergoing RYGB and ILI had improved HRQL after 1 year. The weaker
response of ILI on HRQL, compared to RYGB, may be explained by the difference in weight loss following the two
treatments.
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Introduction
Morbid obesity is understood as a body mass index
(BMI) ≥40 kg/m2 or BMI ≥35 kg/m2 with comorbidities
[1]. Roux-en-Y Gastric Bypass (RYGB) is an effective
and commonly used [2] surgical procedure for treatment
of morbid obesity. Although the majority of patients
may prefer non-surgical intervention, bariatric surgery
has been shown to be more effective than lifestyle inter-
vention at improving weight loss and obesity associated
morbidities [3,4].
Improving patients’ health-related quality of life (HRQL)
is an important treatment goal. This concept refers to
how well an individual functions in daily life and their
perceived well-being [5]. In accordance with the World
Health Organization’s multidimensional definition of
health [6], we conceptualize HRQL as encompassing
physical, mental and emotional dimensions as well as the
burden of obesity specific symptoms.
Few studies have addressed the comparative effects of
bariatric surgery and lifestyle intervention on HRQL. The
Swedish Obese Subjects research program (SOS), a 10-year
non-randomized controlled longitudinal study, compared
patients undergoing various bariatric procedures (n=655)
with patients (n=621) undergoing conventional weight-loss
treatment [7]. Notably, treatment for the conventionally
treated patients was not standardized and treatment
regimens varied according to local practices. The Swedish
study showed that patients who chose surgery lost about
15 times more weight than non-surgically treated patients,
mean (SD) loss of 19.7 (15.8) kg vs. 1.3 (13.8) kg. In
addition, the study reported that the surgical groups
sustained positive outcomes in HRQL compared to non-
surgical matched controls. This effect was mainly explained
by weight loss. A two-year controlled non-randomized
study by Kolotkin et al. [8] found significant improvements
in HRQL in patients undergoing RYGB (n=308) compared
to a control group of patients who sought but did not
undergo RYGB (n=253) and a population-based group of
obese individuals (n=272).
Notably, neither study predefined the lifestyle interven-
tion for the non-surgical groups making comparison
between bariatric surgery and comprehensive lifestyle
programs difficult. The evidence thus remains limited
regarding HRQL following RYGB in comparison to specific
comprehensive and multidisciplinary lifestyle interventions.
In addition, most studies of HRQL in morbid obesity have
focused on the physical and mental aspects, applying gen-
eric instruments of HRQL measurement. However, the de-
velopment of obesity-specific HRQL instruments enables
additional analyses of the emotional and symptomatic
dimensions. Furthermore, only a few studies of HRQL in
the morbidly obese have calculated the effect size (ES) of
change in HRQL, which underscores the clinical relevance
of the various treatments.
An earlier report [9] demonstrated that type 2 diabetes
and obesity-related cardiovascular risk factors such as
hypertension and hyperlipidemia were improved after
both RYGB and a pre-defined part residential multidis-
ciplinary non-surgical intensive lifestyle-intervention
program (ILI). However, the improvements were greatest
in those patients treated with RYGB. This study did not
evaluate the individuals’ subjective notion of well-being
or how their daily life functioned following these two
interventions.
The aim of the present study was to describe and
compare changes in five dimensions of HRQL (physical,
mental, emotional, number of symptoms, and symptom
distress) following RYGB and ILI in morbidly obese
subjects. Secondarily, we wanted to assess the clinical
relevance of the changes in HRQL between and within
these two groups after one year. We hypothesized that
RYGB would be associated with larger improvements of
HRQL than ILI in morbidly obese subjects.
Methods and procedures
This is a preplanned analysis of data from the MOBIL-
study (Morbid Obesity treatment, Bariatric surgery ver-
sus Intensive Lifestyle intervention, Clinical Trials.gov
number NCT00273104), a non-randomized controlled
study designed to compare the effects of bariatric sur-
gery and intensive lifestyle intervention on various
comorbidities, eating behavior and HRQL.
A total of 228 patients were screened, with 47 found
not to be eligible. Of the remaining 181 participants 35
were not enrolled, leaving 146 in the study (Figure 1,
flow of participants).
During the screening procedure all eligible patients
underwent a thorough assessment at the Morbid Obesity
Center by a multidisciplinary team consisting of an in-
ternist, a dietician, a physiotherapist and a trained “obes-
ity” nurse. Patients were provided information about
the possible risks and benefits of an operation and
also encouraged to incorporate their own values and
preferences into the decision-making process. If no
contraindication against surgery existed, the patient and
the physician together agreed upon the most appropriate
choice of therapy; either surgical or conservative [10].
A previous report [9] showed a mean (SD) 1-year weight
loss of 30 (8)% of initial body weight in the RYGB group
and 8 (9)% in the ILI group. This corresponds to a mean
(SD) loss of excess weight above 25 kg/m2 of 67% (18) and
20% (23) (P<0.001) respectively. The patients in the RYGB
group lost a mean (SD) of 14.0 (4.1) BMI points and the ILI
group 3.7 (4.2) BMI points. The number of subjects in the
RYGB group and ILI group who either moved from being
inactive to active (12 vs 18), stayed inactive or active (57 vs
32), or moved from being active to inactive (4 vs 5), differed
significantly between the groups. Overall, there was a greater
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increase in the physical activity level of the lifestyle group
compared to the surgery group.
The Norwegian Regional Ethics Committee for Med-
ical Research approved the study protocol (S-05175),
and the study was performed in accordance with the
Declaration of Helsinki. All participants gave informed
written consent before enrolment.
Variables, measurement and outcomes
The main outcome in the current analysis was the
change in each of the five dimensions of HRQL,
conceptualized as encompassing physical, mental and
emotional dimensions, as well as the number and bur-
den of obesity-specific symptoms. Since we aimed to
compare the effect of two treatment methods, and since
entering both weight loss and type of treatment into the
same statistical analysis led to multicollinearity (r=.81),
weight loss was excluded from the multiple regression
analyses of covariance (ANCOVA). Variables that were
considered possible confounders included age and BMI
prior to intervention, age at the onset of obesity, physical
activity and HRQL-score prior to intervention. Three
questionnaires were used to measure HRQL: the Med-
ical Outcome Study 36 – Item Short Form Health
Figure 1 Flow of patients.
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Survey (SF-36), the Obesity and Weight-Loss Quality of
Life (OWLQOL), and the Weight Related Symptom
Measure (WRSM).
Medical Outcome Study 36 – Item Short Form Health
Survey (SF-36)
SF-36 is a commonly used generic measure of HRQL
based on 36 questions or items [11-13]. Item 2 is not
included in the scoring of the instrument [13]. The
remaining 35 items form eight subscales (physical
function, role physical, bodily pain, general health, role
emotional, social function, vitality, and mental health)
which can be combined into two summary scores; the
physical and mental dimensions [14]. As the validity of
the subscales in morbidly obese patients is uncertain
[15,16] we studied the physical and mental dimensions.
The calculations were performed as recommended by
the scale authors [14], using Norwegian norms [17]
and oblique factor scores to account for the correl-
ation between the two HRQL-dimensions. The scores
were calculated by multiplying each subject’s SF-36
subscale z score by its respective factor coefficient and
then standardizing each to a T score with a mean of
50 and a standard deviation of 10 [14]. Both scales
were set to a range from 0–100, where higher scores
indicate better HRQL.
Obesity and Weight-Loss Quality of Life (OWLQOL)
The OWLQOL [18,19] primarily measures emotions
and feelings [20,21] which are believed to result from
being obese and trying to lose weight. The instrument
consists of 17 statements about weight-related feelings
and emotions which are rated on a seven-point scale
that ranges from 0 (“not at all”) to 6 (“a very great deal”).
The 17 items of the OWLQOL form a scale ranging
from 0–102, with higher scores indicating greater emo-
tional HRQL.
Weight Related Symptom Measure (WRSM)
The WRSM [18,19] measures 20 obesity-specific symp-
toms using two different sets of items. The first set
assesses whether or not the patient is experiencing spe-
cific symptoms. The scoring of this set of items creates
an additive scale summing up the number of symptoms,
ranging from 0–20. The second set of items concerns
the distress of the symptoms, with values from 0 (“not at
all”) to 6 (“bothers a very great deal”). They form a
symptom distress scale ranging from 0–120, where
higher scores indicate greater symptom distress. Both
the OWLQOL and the WRSM were obtained with per-
mission from the Seattle Quality of Life Group, Univer-
sity of Washington.
In sum, the three HRQL questionnaires constitute five
different measurements of HRQL; physical dimension
(SF-36), mental dimension (SF-36), emotional dimension
(OWLQOL), number of obesity symptoms (WRSM),
and distress of obesity symptoms (WRSM).
Changes in scores between two time-points or groups
can be statistically significant. An important follow-up
question is whether the changes are clinically relevant.
There are different approaches to addressing this. Here
we have chosen the effect size (ES) to grade the effi-
ciency of surgical versus nonsurgical treatment [22,23].
Physical activity was assessed through structured
interviews performed by registered dieticians. Time
spent performing light (e.g. casual walking), moderate (e.
g. brisk walking) and vigorous (e.g. jogging) intensity
aerobic physical activities for periods of 10 minutes or
more was recorded. Participants who performed 150
minutes or more per week of moderately intense aerobic
physical activities were considered to be physically ac-
tive, as were those participants who performed 60
minutes or more per week of vigorously intense aerobic
physical activities [24].
Participants
A total of 139 patients completed the MOBIL-study
(Figure 1). At baseline, all patients in both the RYGB
group (n=76) and the ILI group (n=63) completed the
three HRQL instruments. At 1 year follow up 62 (82%)
participants in the RYGB group and 48 (76%) in the ILI
group had completed the questionnaires. In order to as-
sess the representativeness of the sample at the end of
the study we used an independent samples t-test to
compare differences between patients not completing
the questionnaires at the end of the study versus
completers. Patients who did not complete the
questionnaires after 1 year (n=29) were comparable with
those who did (n=110) with regards to baseline HRQL,
gender, age, body weight, employment status, and weight
loss after 1 year (data not shown).
Interventions
During follow-up, patients allocated to RYGB were
examined by a bariatric surgeon 6 weeks after surgery,
while patients were seen by a dietician quarterly, usually
in groups of 12–16. The patients in the ILI group were
admitted to a rehabilitation center specializing in the
care of morbidly obese patients. The aim was to attain a
sustained 1-year weight loss ≥10%. Each patient was
encouraged to increase their physical activity and to
normalize eating habits. The program intended to in-
crease each patient’s self-efficacy in dealing with their
weight problem, as well as an improvement in self-
esteem.
The 1-year lifestyle program comprised four stays at the
rehabilitation center – three 5-day stays in weeks 1, 26,
and 51, and a four-week stay from weeks 13–17 (Figure 2).
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The daily schedule was divided between organized daily
physical activity (3–4 hours) and various psychosocially-
oriented interventions combined with a motivational
approach both in group sessions and individual sessions
(3–4 hours). These sessions were supervised by a medical
doctor, nutritionists, physiotherapists and mental health-
trained nurses. No special diet or weight-loss drugs were
prescribed, but patients were encouraged to follow the
guidelines of the Norwegian National Council of Nutrition
[25], which recommends that the daily intake of protein,
fat, carbohydrate and alcohol should account respectively
for 10–20, <30, 50–60, and <5% of energy consumed. In
addition, the patients were asked to reduce their daily total
energy intake, but not using calorie-counting. Outside of
these stays patients were contacted by phone once every 2
weeks. They were also encouraged to self-monitor their
eating habits and physical activities in a pre-fabricated
diary, as well as to consult their general practitioner for
weight measurement and follow-up every four weeks.
Statistical methods
Data are presented as mean (SD) or n (%) unless other-
wise stated. Skewed data were transformed to approxi-
mate normality using natural logarithms. To assess the
reliability of the HRQL-scales we calculated Cronbach’s
alpha coefficients.
After applying Little’s test of randomness of missing
data, missing values (SF-36:23.5%, OWLQOL:24.5%,
WRSM:23.7%) were imputed using multiple imputation.
The imputation model consisted of the HRQL-scores,
physical activity at baseline and 1 year, and age of onset
of obesity as predictor and imputation variables, and
treatment, gender, age, baseline BMI, marital status, em-
ployment, and education as predictor variables. Through
a fully conditional specification model, applying linear
regression as the prediction method for scale variables
and two-way interactions for categorical variables, we
generated twenty complete datasets for each of the
HRQL-scores with 10 iterations per dataset. The statis-
tical analyses were performed on each complete dataset,
and thereafter the multiple analyses results were
combined to achieve single estimates. The combined
estimates are presented. Observing the fraction of
missing information, relative increase variance, and rela-
tive efficiency, the imputed data-sets (n=139) were com-
parable with the original data-set (n=110) in terms of
the imputed variables (data not shown).
Within-group analyses in both groups were performed
using paired samples t-test. Between-group comparisons
at baseline were analyzed using independent samples t-
test for continuous variables and χ2 for categorical
variables.
Within groups ES was calculated as the mean HRQL
change score between 1 year and baseline divided by the
standard deviation of the baseline HRQL. Between
groups ES was calculated as the difference in mean
HRQL change score between groups at 1 year divided by
the standard deviation of baseline HRQL [22,23]. An ES
from .20–.49 was considered small, .50–.79 as moderate,
and greater than .80 as large [22,23].
In order to avoid problems of regression towards the
mean [26,27], we applied one-way between-group ana-
lyses of covariance (ANCOVA) to compare the effect of
RYGB and lifestyle intervention on five dimensions of
HRQL. Age at baseline, age at the onset of obesity, BMI
at baseline, physical activity at baseline, and baseline
HRQL-scores were used as covariates in each of the five
analyses [28]. Assessments of normality, linearity, homo-
geneity of variance and regression slopes were
conducted to ensure assumptions for the ANCOVA.
The unadjusted changes from baseline in the RYGB
group and ILI group, together with the adjusted between
group differences (95% CI), are reported. To account for
the percentage explained variance in the dependents,
calculations of partial eta squared (ηp2) were performed.
To test the effect of weight reduction (instead of treat-
ment choice) on HRQL, multiple linear regression ana-
lyses were conducted with each of the 12 months HRQL
changes (physical, mental, emotional, number of obesity
symptoms, and symptom distress) as dependents, with
gender, age at baseline, age at the onset of obesity, BMI
at baseline, physical activity at baseline, and weight
change in per cent of baseline weight as independents.
Throughout, we report two-tailed P values, with P<.05
was considered to be statistically significant. The statis-
tical analysis was conducted using SPSS v.18.0.
Results
Internal consistency
The inter-item analyses showed Cronbach’s alpha coef-
ficients >.80, indicating that intercorrelations among the
items is high and that there is a high reliability for all
of the HRQL-scales (physical, mental, and emotional
dimensions, number of symptoms, and symptom
distress).
Figure 2 Schedule of stays during the 1-year intensive lifestyle intervention program at the rehabilitation centre.
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Patients
Baseline demographic characteristics are summarized in
Table 1. Compared to the ILI group, the patients in the
RYGB group had a higher BMI (ES=.49), were younger
(ES=.36), had earlier onset of obesity (ES=.47), and had
lower physical (ES=.50) and emotional HRQL (ES=.42).
Changes in the five main dimensions of HRQOL
Adjusted between group analyses, controlling for the
effects of treatment, age at baseline, age at the onset of
obesity, BMI at baseline, physical activity at baseline,
and baseline HRQL-scores, showed that compared to
the ILI group, the RYGB group had statistically signifi-
cant higher adjusted mean improvement in all HRQL-
measurements, especially the emotional dimension
(Table 2). Based on calculations of ηp2, type of treatment
predicted 19.7% of the variance (ES=.83) in the physical
dimension change score, 9.8% (ES=.50) in the mental di-
mension change score, 22.6% (ES=1.06) in the emotional
dimension change score, 7.7% (ES=.56) in the number of
symptoms, and 8.1% (ES=.37) in the symptom distress
change score.
Unadjusted within-group analyses showed that both
groups reported improvements in all five HRQL-
measurements (Figures 3 and 4). All effect sizes were
large within the RYGB group and small to moderate
within the ILI group.
Changes in self-reported symptom distress
Twenty common obesity specific health problems
associated with obesity are listed in Table 3. Compared
to the ILI group, the RYGB group showed greater im-
provement in ailments such as reduced physical stamina,
joint pain, snoring, sleep problems, skin irritation, water
retention, and foot problems. Only the improvements of
physical stamina and joint pain showed large effect sizes
between groups. On the other hand, the RYGB group
reported higher sensitivity to cold (Table 3), and this dif-
ference was considered large.
The effect of weight reduction
The linear regression analyses revealed significant
associations between weight reduction in per cent of
baseline weight, when controlling for the effect of gen-
der, age at baseline, age at the onset of obesity, BMI at
baseline, and physical activity at baseline. The analyses
of weight loss on HRQL change showed a standardized
beta-coefficient of –.430 (p<.001) on the physical dimen-
sion, –.288 (p=.004) on the mental dimension, –.432
(p<.001) on the emotional dimension, .287 (p=.008) on
number of symptoms, and .274 (p=.009) on reduction of
symptom pressure.
Discussion
Key results
In this non-randomized clinical trial comparing RYGB
to ILI, we found that RYGB was more effective at im-
proving all HRQL-dimension scores (Table 2). In par-
ticular, the RYGB group had a clinically relevant effect
on changes in the emotional dimension (ES=1.06) and in
the physical dimension (ES=.83). Within the RYGB
group all HRQL dimensions showed large improvements
(ES>.80). Within the ILI group, changes were moderate
(ES>.50 and <.79).
Previous studies have shown that patients treated with
RYGB experience larger improvements of HRQL
compared to those undergoing conventional weight loss
treatment [7,8]. However, these studies did not compare
the surgical procedures with a part residential lifestyle
intervention program. In addition, the authors did not
assess the effect sizes of the treatments on the various
dimensions of HRQL.
The improvement of the emotional dimension of
HRQL was particularly pronounced in the RYGB group.
Table 1 Demographic, socioeconomic and clinical
characteristics of 139 morbidly obese individuals who
chose a part residential intensive lifestyle intervention
program (ILI) or gastric bypass surgery (RYGB)
Variable Total RYGB ILI P-
value(n=139) (n=76) (n=63)
Women (n, %) 97 (70%) 53 (70%) 44 (70%) .569
Age (years), mean (SD) 46 (11) 43 (11) 47 (11) .021
Onset of obesity (n, %)
<12 years 35 (25%) 25 (33%) 10 (16%)
12-20 years 28 (20%) 17 (22%) 11 (17%)
>20 years 76 (55%) 34 (45%) 42 (67%) .003
BMI (kg/m2), mean (SD) 44 (6) 46 (6) 43 (5) <.001
Married/cohabitant, (n, %) 83 (60%) 45 (60%) 38 (60%) .895
Employment (n, %) 82 (59%) 40 (53%) 42 (67%) .094
Length of education (n, %)
Basic (<9 year) 32 (23%) 18 (24%) 14 (22%)
Intermediate (9–12 year) 75 (54%) 44 (58%) 31 (49%)
Higher (>12 year) 2 (23%) 14 (18%) 18 (29%) .358
Physical activity (n, %)
Low 115 (83%) 67 (88%) 48 (76%)
High 24 (17%) 9 (12%) 15 (24%) .063
Quality of life scores, mean (SD)
Physical dimension a 36 (10) 34 (10) 39 (10) .018
Mental dimension a 41 (11) 41 (11) 42 (11) .690
Emotional dimension b 36 (24) 32 (23) 42 (24) .047
Number of symptoms c 11 (4) 12 (4) 11 (4) .343
Symptom distress d 41 (21) 43 (21) 38 (20) .173
(a) SF-36 (scale 0–100). (b) OWLQOL (scale 0–102). (c) WRSM (scale 0–20). (d)
WRSM (scale 0–120).
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A possible explanation may be that the massive weight
loss following RYGB after 1 year reduced the patients
feeling of being fat and, accordingly, improved their
feeling of being “normal”. The surgical procedure per se
seems to help many patients gain control over their food
intake, thus confirming the clinical observation of more
“relaxed” patients one year after surgery. In addition, as
suggested by Fabricatore and Wadden [29], the negative
stigma associated with obesity may be caused by an un-
desirable body appearance and by the “character defects”
other people associate with this appearance. In our
terms, as patients start to experience massive weight
loss, their perception of their own body is expected to
improve, as is the perceptions of other people. This in-
ternal and external reduction of stigma may be followed
by an improvement in self-esteem and positive emotions
among obese patients experiencing massive weight loss.
However, a massive weight loss and a less stigmatizable
body appearance may not be the only explanations as to
the improvements in the emotional HRQL. The ILI
group also reported significant improvements in the
emotional dimension of HRQL after 1 year, even though
the effect size was moderate. The moderate effect in the
ILI group may be explained by the more moderate
weight loss in this group. However, weight loss may not
be the only explanation. It is conceivable that the inter-
vention itself added to the improvement of emotional
HRQL in the ILI group. The group-based focus and mo-
tivational approach in the lifestyle program aimed at
increasing self-efficacy, self-esteem and mood state. Pre-
vious studies seem to support this notion. Programs fo-
cusing on motivationally-oriented group sessions report
as little as 3 kg. weight loss (e.g. from 103 to 100 kg.)
but have found significant improvements in mood state
as measured with validated psychometric instruments
[30]. In another study of 440 obese patients with
Table 2 One way between-groups analysis of variance on five dimensions of HRQL in morbidly obese patients
undergoing either RYGB or ILI
Changes from baseline Adjusted between group
difference, mean (95% CI)
P ES
RYGB ILI
(n=76) (n=63)
Physical dimensiona 16.8 (9.7) 4.9 (9.4) 8.6 (4.6,12.6) <.001 .83
Mental dimensiona 9.6 (9.1) 3.5 (8.9) 5.4 (1.5,9.3) .007 .50
Emotional dimensionb 42.7 (25.5) 15.7 (21.7) 25.2 (15.0,35.4) <.001 1.06
Number of obesity symptomsc −5.3 (4.6) −2.9 (4.7) −2.3 (−4.5,-.6) .012 .56
Symptom distressd −25.2 (20.7) −14.3 (16.5) −8.7 (−15.4,-1.8) .013 .37
Adjustments were made for age at the onset of obesity and baseline values of age, BMI physical activity level, and HRQL. (a) SF-36 (scale 0–100). (b) OWLQOL
(scale 0–102). (c) WRSM (scale 0–20). (d) WRSM (scale 0–120). Statistical significance (P) and effect size (ES) are reported.
Figure 3 Mean scores on five HRQL-scales at baseline and 1 year in morbidly obese patients who underwent a part residential
intensive lifestyle intervention program (n=63). (a) SF-36 Physical dimension (0–100). (b) SF-36 Mental dimension (0–100). (c) OWLQOL
Emotional dimension (0–102). (d) WRSM symptom number score (0–20). (e) WRSM symptom severity score (0–120). Unadjusted mean change
scores and 95% CI. P and ES-values for within-group changes.
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coronary artery disease, group support was reported to
be associated with a significant improvement in the
mental dimension of HRQL despite moderate weight
loss [31].
The self-reported symptom scores before treatment
in both groups corroborate the well-known associ-
ation between high BMI, several comorbidities and
physical HRQL. After 1 year we found that patients
in both groups reported significantly fewer symptoms.
The improvements in joint pain and physical stamina
in the RYGB group were notable and may, together
with improvements in skin irritation, water retention,
foot problems, and shortness of breath, have resulted
in easier performance of everyday personal hygiene,
housekeeping, shopping and walking. All these tasks
are central elements of the physical dimension of
HRQL [11], which in the RYGB group showed a large
effect size (ES=.83).
Another distressing obesity-associated symptom is
snoring and tiredness. These symptoms were markedly
reduced in the RYGB group. This finding supports a re-
port from the SOS-study which found a substantial re-
duction in symptoms of sleep apnoea and daytime
sleepiness in the bariatric surgery group after 2 years
[32]. One might speculate that increased sleep quality
and reduced daytime sleepiness may lead to increased vi-
tality and improved functioning at work or during other
daily activities, which also is embedded in the physical
dimension of HRQL [11]. The finding of increased sensi-
tivity to cold in the RYBG group is probably connected
to the higher loss of fat mass with surgery [33], and
Figure 4 Mean scores on five HRQL-scales at baseline and 1 year in morbidly obese patients who underwent RYGB (n=76). (a) SF-36
Physical dimension (0–100). (b) SF-36 Mental dimension (0–100). (c) OWLQOL Emotional dimension (0–102). (d) WRSM symptom number score
(0–20). (e) WRSM symptom distress score (0–120). Unadjusted mean change scores and 95% CI. P and ES-values for within-group changes.
Table 3 1-year changes in reported symptom distress
between groups of morbidly obese patients undergoing
RYGB (n=76) or intensive lifestyle intervention (n=63)
Symptom RYGB ILI P ES
Physical stamina −2.7 (2.5) -.7 (2.6) <.001 .913
Pain in the joints −2.4 (2.2) -.7 (2.0) .002 .891
Snoring −2.3 (2.2) -. 8 (2.0) .002 .721
Sensitivity to cold 1.4 (2.2) .1 (1.9) .005 .921
Skin irritation −1.2 (1.9) -.3 (1.8) .032 .493
Sleep problems −1.3 (2.2) -.4 (2.2) .043 .406
Water retention −1.5 (1.9) -.6 (2.0) .047 .456
Foot problems −2.2 (2.6) −1.1 (2.5) .050 .541
Back pain −1.6 (2.0) -.9 (1.7) .071 .350
Tiredness −1.6 (2.2) -.7 (2.2) .089 .460
Shortness of breath −2.2 (2.1) −1.4 (1.9) .093 .442
Leakage of urine -.8 (1.6) -.3 (2.0) .220 .267
Frequent urination -.8 (2.1) -.3 (1.7) .281 .244
Increased sweating −1.3 (2.1) -.9 (2.2) .339 .246
Loss of sexual desire −1.4 (2.6) -.9 (2.6) .393 .215
Lightheadedness .3 (1.8) -.2 (1.5) .517 .164
Increased thirst -.9 (1.9) -.7 (1.8) .569 .136
Increased irritability -.4 (2.1) -.7 (2.1) .595 .140
Increased appetite -.2 (2.2) -.3 (2.0) .849 .044
Sensitivity to heat −1.5 (2.4) −1.6 (2.2) .987 .004
Self-reported data from the Weight-related Symptom Measure (WRSM). Scale
from 0 (bothers not at all) to 6 (bothers a very great deal). Data are given as
given as mean difference in scores (SD). P and ES-values for
between-group differences.
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is a phenomenon commonly observed within clinical
practice.
The overall reduction of the number of symptoms and
symptom distress in the ILI group was statistically sig-
nificant, although with moderate effect sizes. However,
compared to the RYGB group more patients in the ILI
group were physically active at baseline, whilst the in-
crease in physical activity after one year was larger in
the ILI group than the RYGB group [9]. We believe that
the combination of the overall reduction in symptom
distress and higher activity levels contributed to an im-
provement of the physical HRQL in the ILI group, even
though the weight loss was moderate. There is a consist-
ent association of higher HRQL scores with higher levels
of physical activity among healthy adults in cross-
sectional studies [34], and this association is stronger on
the physical dimension of the HRQL than the mental di-
mension [34]. We also know that interventions combin-
ing physical activity and diet improve the physical
dimension of HRQL but not the mental dimension
among older obese individuals with knee ostoearthritis
[35].
As with the emotional and physical aspects of HRQL,
the mental aspects also improved in both groups after 1
year. The RYGB group scored significantly better than the
ILI group. Other studies have found similar results [7,8]
between bariatric surgery and non-standardised lifestyle
programs. However, our study extends previous findings
to include the comparative effects of a structured, system-
atic part residential lifestyle program. The improvements
in the mental dimension of HRQL may be explained by
the greater weight loss and improvement of psychosocial
status including social relations and employment oppor-
tunities [36]. A deeper understanding of the relationship
between weight loss and improvement of the emotional
and mental dimension of HRQL may necessitate research
designs other than a quantitative approach.
We have previously shown [9] bariatric surgery to be su-
perior to lifestyle treatment in regards to weight loss.
However, the effect of weight loss on improvement of
HRQL may have been moderated by the lifestyle treat-
ment regime itself. In particular, our results suggest that a
“comprehensive and multidisciplinary program intended
to increase the patient’s self-efficacy in dealing with their
weight problem” may impact upon HRQL, independent of
weight loss.
As reported earlier our study has limitations [9]. Al-
though preferable when conducting a clinical trial, we
did not find randomization to be appropriate. According
to Norwegian guidelines, treatment seeking morbidly
obese subjects should be offered either conservative or
surgical therapy. We therefore considered it unethical to
assign patients to surgery if they qualified for a lifestyle
intervention program and preferred this course of
treatment to surgery. This stance also held vice versa.
Thus, the differences between the groups may not be
causally associated with choice of treatment. Further, the
study was limited to a 1-year time span. The long term
effects of the two interventions on HRQOL may differ
due to intervening life events, complications of surgery,
or other reasons, and these require further study.
Lifestyle intervention for morbid obesity comprises of
many different methods, from very low calorie diets to
comprehensive psychosocially oriented programs com-
bining diets, physical activity and behavioral interven-
tion. There is little robust evidence identifying the most
effective lifestyle strategies for treatment and prevention
of obesity in general and in morbid obesity in particular
[37]. Hence, research must focus on a variety of lifestyle
intervention programs in order to to identify the most
beneficial treatment regimens. Our findings indicate
that a pre-defined part residential multidisciplinary
non-surgical weight loss program with a psychosocially-
oriented motivational approach is a promising interven-
tion when aiming to increase HRQL in morbidly obese
patients. However, larger weight losses may be necessary
to maximize the beneficial effects.
Conclusion
Our study shows that following a part residential multidis-
ciplinary lifestyle intervention program, morbidly obese
patients improved their HRQL, although patients under-
going bariatric surgery experienced larger improvements
in HRQL after 1 year. The higher clinical relevance of
bariatric surgery on HRQL may be explained by a higher
weight loss.
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